HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Reckova Selected Research

Cardiotoxicity

11/2007Increased cardiotoxicity of sorafenib in sunitinib-pretreated patients with metastatic renal cell carcinoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Reckova Research Topics

Disease

2Neoplasms (Cancer)
12/2017 - 01/2009
1Lymphadenopathy
01/2010
1Brain Neoplasms (Brain Tumor)
01/2010
1Nonseminomatous germ cell tumor
01/2009
1Germ Cell and Embryonal Neoplasms (Germ Cell Tumor)
01/2009
1Renal Cell Carcinoma (Grawitz Tumor)
11/2007
1Cardiotoxicity
11/2007

Drug/Important Bio-Agent (IBA)

1Hormones (Hormone)IBA
12/2017
1Tumor Biomarkers (Tumor Markers)IBA
01/2009
1Sorafenib (BAY 43-9006)FDA Link
11/2007
1Sunitinib (Sutent)FDA Link
11/2007

Therapy/Procedure

1Radiotherapy
01/2010
1Drug Therapy (Chemotherapy)
01/2009
1Salvage Therapy
01/2009